Skip to main content

Table 1 Demographic and clinico-pathological characteristics of included patients and pathological tumor characteristics

From: Immune infiltrating cells in duodenal cancers

Patients and tumor characteristics

Variable

Adenocarcinomas (n = 15)

Sexa

 Female

3 (20%)

 Male

12 (80%)

Age at operationb

73 (65–78)

Clavien-Dindo ≥ IIIba

5 (33%)

Post-operative mortalitya

3 (20%)

DA on adenomaa

3 (20%)

Portion of duodenum involveda

 I

1 (7%)

 II

13 (86%)

 III

1 (7%)

 IV

0 (0%)

TNM staging 7th edition

 Ta

1–2

2 (13%)

3–4

13 (87%)

Na

 0

7 (47%)

 1

2 (13%)

 2

6 (40%)

Stage grouping 7th editiona

 I

2 (13%)

 II

5 (34%)

 III

8 (53%)

Histological grade (G)a

 1–2

7 (46%)

 3–4

8 (54%)

Resection status (R)a

 0, n (%)

14 (93%)

 1, n (%)

1 (7%)

 2, n (%)

0 (0%)

n° of retrieved lymph nodesb

23 (14–28)

n° of positive lymph nodesb

2 (0–3)

Lymph node ratiob

0.689 (0–0.115)

Perineural invasiona

5 (33%)

Lymphovascular invasiona

5 (33%)

Adjuvant chemotherapya

6 (40%)

Adjuvant radiotherapya

0 (0%)

Disease recurrencea

3 (20%)

Disease related deatha

3 (20%)

  1. Only adenocarcinoma patients have been included. a n (%); b median (IQR)